
Currently out of the existing stock ratings of Tiago Fauth, 171 are a BUY (77.38%), 42 are a HOLD (19%), 8 are a SELL (3.62%).
Analyst Tiago Fauth, currently employed at RAYMOND JAMES, has had 46.7% of price targets met with an average potential upside of 23.9%, reached in 129 days on average. Previously, Tiago Fauth worked at WELLS FARGO.
Tiago Fauth has documented 442 price targets and ratings displayed on 44 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LQDA, Liquidia Technologies.
Analyst best performing recommendations are on HGEN (HUMANIGEN).
The best stock recommendation documented was for HGEN (HUMANIGEN) on 7/13/2022. The price target of $0.5 was fulfilled within 2 days with a profit of $0.11 (18.03%), with a performance score of 90.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Nov-2026
$15
$3.51 (30.55%)
$11
5 days ago
(11-Nov-2026)
Buy Since 05-Jan-2021
$14
$2.51 (21.85%)
$9
6 days ago
(10-Nov-2026)
Hold Since 24-Sep-2026
$13
$1.51 (13.14%)
$24
1 months 23 days ago
(24-Sep-2026)
1/3 (33.33%)
$0.35 (2.77%)
4
Buy Since 05-May-2026
$12
$0.51 (4.44%)
$11
3 months 10 days ago
(06-Aug-2026)
3/3 (100%)
$5.47 (83.77%)
53
Buy Since 16-May-2025
$12
$0.51 (4.44%)
$10
5 months 25 days ago
(22-May-2026)
5/5 (100%)
$6.8 (130.77%)
275
Which stock is Tiago Fauth most bullish on?
Which stock is Tiago Fauth most reserved on?
What Year was the first public recommendation made by Tiago Fauth?